1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Loblaw Companies Limited
  6. News
  7. Summary
    L   CA5394811015

LOBLAW COMPANIES LIMITED

(L)
  Report
Delayed Toronto Stock Exchange  -  04:15 2022-08-09 pm EDT
114.94 CAD   -0.54%
08/02Pangea Natural Foods Lists Products in Loblaw's British Columbia and Alberta Stores
MT
07/29George Weston Q2 Adjusted Diluted EPS $2.23 Vs $1.80 Year Ago; Revenue $12.98 Billion Vs $12.64 Billion
MT
07/29GEORGE WESTON BRIEF : Adjusted diluted net earnings per common share from continuing ops $2.23 in Q2 2022, an increase of $0.43 per common share, or 23.9%, compared to Q2 2021
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Lethbridge Superstore offers Alberta's first walk-in health clinic led by pharmacists

06/24/2022 | 04:44pm EDT

LETHBRIDGE, Alta. — A Canadian retailer has partnered with the University of Alberta to offer the province's first pharmacist-led health clinic as part of a pilot project.

Loblaw Companies Ltd. said the walk-in clinic, which opens to patients Monday, is located inside the Real Canadian Superstore in Lethbridge.

Jeff Leger, head of pharmacy for Loblaw and president of Shoppers Drug Mart, said pharmacists in Alberta are uniquely positioned to relieve some of the burden on the province's health-care system.

"In Alberta, there's great scope of practice," he said. "Pharmacists are able to do quite a number of things to help people with either minor illnesses or pain or chronic conditions, so that's what we're doing.

"We're actually going to offer primary care through the pharmacists."

Health Minister Jason Copping, who attended the announcement in Lethbridge, said in a statement that the clinic will be a place where people can get help quickly and easily.

"Pharmacists have the knowledge and expertise to contribute more to the primary care team, and government recognizes that," he said.

Copping said it's one way the province is increasing access to primary care, which is a major challenge in the health-care system.

"Access is an issue right across Canada; and like other challenges, it was an issue even before COVID, but of course the pandemic has made it much tougher," he said.

Copping said the province is also working with Alberta Health Services to recruit more family doctors in places like Lethbridge.

This report by The Canadian Press was first published on June 24, 2022.

© 2022 The Canadian Press. All rights reserved., source Canadian Press DataFile

All news about LOBLAW COMPANIES LIMITED
08/02Pangea Natural Foods Lists Products in Loblaw's British Columbia and Alberta Stores
MT
07/29George Weston Q2 Adjusted Diluted EPS $2.23 Vs $1.80 Year Ago; Revenue $12.98 Billion V..
MT
07/29GEORGE WESTON BRIEF : Adjusted diluted net earnings per common share from continuing ops $..
MT
07/28BMO Capital's Take on Loblaw Keeps Market Perform, Ups Target to $123
MT
07/28Alberta Court Releases First Decision Regarding Masking Policies + Constructive Dismiss..
AQ
07/28National Bank Raises Loblaw Target to $127, Keeps Outperform, But Removes "Top Pick" St..
MT
07/27Alberta Court Finds Employee Resigned And Was Not Constructively Dismissed When He Did ..
AQ
07/27TRANSCRIPT : Loblaw Companies Limited, Q2 2022 Earnings Call, Jul 27, 2022
CI
07/27Loblaw second quarter profit increases to $387M amid strength in drugstores, discount
AQ
07/27Loblaw Reports Q2 Adjusted EPS Beat of $1.69; Revenue of $12.85 Billion
MT
More news
Analyst Recommendations on LOBLAW COMPANIES LIMITED
More recommendations
Financials
Sales 2022 55 010 M 42 696 M 42 696 M
Net income 2022 1 825 M 1 416 M 1 416 M
Net Debt 2022 11 756 M 9 124 M 9 124 M
P/E ratio 2022 21,0x
Yield 2022 1,36%
Capitalization 37 653 M 29 225 M 29 225 M
EV / Sales 2022 0,90x
EV / Sales 2023 0,87x
Nbr of Employees 220 000
Free-Float 45,0%
Chart LOBLAW COMPANIES LIMITED
Duration : Period :
Loblaw Companies Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LOBLAW COMPANIES LIMITED
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Last Close Price 114,94 CAD
Average target price 126,00 CAD
Spread / Average Target 9,62%
EPS Revisions
Managers and Directors
Galen G. Weston Executive Chairman, President & CEO
Richard Dufresne Chief Financial Officer
David Markwell Chief Technology & Analytics Officer, Executive VP
Robert Sawyer Chief Operating Officer
Robert Wiebe Chief Administrative Officer
Sector and Competitors
1st jan.Capi. (M$)
LOBLAW COMPANIES LIMITED11.50%29 478
WALMART INC.-12.52%349 798
SYSCO CORPORATION9.80%44 192
KROGER4.40%33 696
WOOLWORTHS GROUP LIMITED0.58%32 349
AHOLD DELHAIZE N.V.-12.49%26 750